Literature DB >> 20700657

Impact and characteristics of quality of life in Japanese patients with multiple sclerosis.

Hiromi Kikuchi1, Nobuhiro Mifune, Masaaki Niino, Sadayoshi Ohbu, Jun-ichi Kira, Tatsuo Kohriyama, Kohei Ota, Masami Tanaka, Hirofumi Ochi, Shunya Nakane, Masaji Maezawa, Seiji Kikuchi.   

Abstract

PURPOSE: To evaluate health-related quality of life (HRQOL) in Japanese patients with multiple sclerosis (MS) and investigate associations between the results of these QOL assessments and disease severity.
METHODS: One-hundred sixty-three Japanese MS patients completed a questionnaire battery comprising the Functional Assessment of MS (FAMS), the Nottingham Adjustment Scale-Japanese version (NAS-J), and the European QOL scale (EQ-5D). Additional five factors affecting QOL as identified by MS patients in a focus group interview were also investigated: employment status, change of income, availability of disease information, communication with medical staff, and care received. Disease severity was determined using the Expanded Disability Status Scale (EDSS).
RESULTS: There was a strong negative correlation of the subscale scores for mobility, symptoms, emotional well-being, thinking and fatigue, and additional concerns on the FAMS with EDSS score. For the NAS-J, only acceptance of the condition was correlated with disease severity. Among the five additional aspects of the condition identified by patients, employment status, income, and disease information were shown to be important for maintaining QOL in patients with MS.
CONCLUSIONS: Support for finding employment and having increased or maintained household income and readily available information about the disease contribute to improving QOL in Japanese MS patients.

Entities:  

Mesh:

Year:  2010        PMID: 20700657     DOI: 10.1007/s11136-010-9725-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  47 in total

1.  Quality of life: an outcome of care measure. The case of multiple sclerosis.

Authors:  Rueben Eldar
Journal:  Croat Med J       Date:  2003-12       Impact factor: 1.351

2.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

3.  Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years.

Authors:  M Osoegawa; J Kira; T Fukazawa; K Fujihara; S Kikuchi; M Matsui; T Kohriyama; G Sobue; T Yamamura; Y Itoyama; T Saida; K Sakata; H Ochi; T Matsuoka
Journal:  Mult Scler       Date:  2008-11-05       Impact factor: 6.312

4.  Value of health-related quality of life to predict disability course in multiple sclerosis.

Authors:  M A J Visschedijk; B M J Uitdehaag; M Klein; E van der Ploeg; E H Collette; L Vleugels; L E M A Pfennings; E L J Hoogervorst; H M van der Ploeg; C H Polman
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

5.  Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS).

Authors:  S M Gold; C Heesen; H Schulz; U Guder; A Mönch; J Gbadamosi; C Buhmann; K H Schulz
Journal:  Mult Scler       Date:  2001-04       Impact factor: 6.312

6.  A health-related quality of life measure for multiple sclerosis.

Authors:  B G Vickrey; R D Hays; R Harooni; L W Myers; G W Ellison
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

7.  Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis.

Authors:  R H B Benedict; I Fishman; M M McClellan; R Bakshi; B Weinstock-Guttman
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

8.  [Validation of the Japanese version of the Parkinson's Disease Questionnaire].

Authors:  Junko Kohmoto; Sadayoshi Ohbu; Masanori Nagaoka; Yoshimi Suzukamo; Tameko Kihira; Yoshikuni Mizuno; Yoichi M Ito; M Hith; Takuhiro Yamaguchi; Yasuo Ohashi; Shunichi Fukuhara; Tomoyoshi Kondo
Journal:  Rinsho Shinkeigaku       Date:  2003-03

9.  A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue.

Authors:  Kirsten van Kessel; Rona Moss-Morris; Ernest Willoughby; Trudie Chalder; Malcolm H Johnson; Elizabeth Robinson
Journal:  Psychosom Med       Date:  2008-02-06       Impact factor: 4.312

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  6 in total

Review 1.  A review of the psychometric properties of generic utility measures in multiple sclerosis.

Authors:  Ayse Kuspinar; Nancy E Mayo
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

2.  Using existing data to identify candidate items for a health state classification system in multiple sclerosis.

Authors:  Ayse Kuspinar; Lois Finch; Simon Pickard; Nancy E Mayo
Journal:  Qual Life Res       Date:  2013-12-15       Impact factor: 4.147

3.  Associations between demographic, disease related, and treatment pathway related variables and health related quality of life in primary care patients with coronary heart disease.

Authors:  Lena Kramer; Oliver Hirsch; Kathrin Schlössler; Susanne Träger; Erika Baum; Norbert Donner-Banzhoff
Journal:  Health Qual Life Outcomes       Date:  2012-07-09       Impact factor: 3.186

4.  Burden of disease of multiple sclerosis in Korea.

Authors:  Soo-Eun Chung; Hae-Kwan Cheong; Jae-Hyun Park; Ho Jin Kim
Journal:  Epidemiol Health       Date:  2012-11-30

5.  Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis.

Authors:  Hiromi Kikuchi; Nobuhiro Mifune; Masaaki Niino; Jun-Ichi Kira; Tatsuo Kohriyama; Kohei Ota; Masami Tanaka; Hirofumi Ochi; Shunya Nakane; Seiji Kikuchi
Journal:  BMC Neurol       Date:  2013-01-22       Impact factor: 2.474

6.  Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries.

Authors:  Kaoru Yamabe; Marco D DiBonaventura; Chris L Pashos
Journal:  Clinicoecon Outcomes Res       Date:  2019-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.